CJC-1295 DAC 5mg

CJC-1295 DAC (Drug Affinity Complex) is a synthetic peptide analogue consisting of 30 amino acids, modified to include a drug affinity complex designed to increase molecular stability in experimental settings. It is supplied exclusively for laboratory research purposes.

In research environments, CJC-1295 DAC is utilised as a model peptide compound in experimental studies examining peptide stability, peptide–protein interactions, and molecular signalling pathways under controlled laboratory conditions. Its modified structure and extended stability profile make it of interest in in vitro and preclinical research focused on comparative peptide behaviour and structure–activity relationships.

CJC-1295 DAC is referenced in scientific literature as a research tool in non-clinical experimental models. Researchers may employ this peptide in controlled laboratory investigations where defined molecular structure, reproducibility, and extended peptide stability are required for mechanistic study.

Product Information

• Peptide: CJC-1295 DAC
• Sequence length: 30 amino acids
• Form: Lyophilised powder
• Purity: ≥99% by HPLC testing
• Testing: Independently third-party tested
• Documentation: Batch-specific analytical documentation available where provided.

Important Notice

This product is supplied strictly for research use only.
It is not intended for human or veterinary use, and is not a medicinal product, food supplement, or cosmetic ingredient.
No claims are made regarding safety, efficacy, or suitability for any therapeutic, diagnostic, or consumable application.